KDM5B
MOLECULAR TARGETlysine demethylase 5B
KDM5B (lysine demethylase 5B) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KDM5B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ebselen | 4.74 | 113 |
| 2 | esculetin | 3.64 | 37 |
| 3 | n oxalylglycine | 3.43 | 30 |
| 4 | caffeic acid | 0.69 | 1 |
| 5 | bdb chembl3786596 us9611221 example 42 us10179769 example 42 us9725441 example 42 us | 0.69 | 1 |
About KDM5B as a Drug Target
KDM5B (lysine demethylase 5B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented KDM5B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KDM5B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.